rs281875172

Variant summary

Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PM5PP3_Strong

The NM_000062.3(SERPING1):​c.695T>A​(p.Ile232Lys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I232R) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 32)

Consequence

SERPING1
NM_000062.3 missense

Scores

9
5
5

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2O:1

Conservation

PhyloP100: 4.39
Variant links:
Genes affected
SERPING1 (HGNC:1228): (serpin family G member 1) This gene encodes a highly glycosylated plasma protein involved in the regulation of the complement cascade. Its encoded protein, C1 inhibitor, inhibits activated C1r and C1s of the first complement component and thus regulates complement activation. It is synthesized in the liver, and its deficiency is associated with hereditary angioneurotic oedema (HANE). Alternative splicing results in multiple transcript variants encoding the same isoform. [provided by RefSeq, May 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 8 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-57606019-T-G is described in Lovd as [Pathogenic].
PP3
MetaRNN computational evidence supports a deleterious effect, 0.98

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SERPING1NM_000062.3 linkuse as main transcriptc.695T>A p.Ile232Lys missense_variant 5/8 ENST00000278407.9 NP_000053.2
SERPING1NM_001032295.2 linkuse as main transcriptc.695T>A p.Ile232Lys missense_variant 4/7 NP_001027466.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SERPING1ENST00000278407.9 linkuse as main transcriptc.695T>A p.Ile232Lys missense_variant 5/81 NM_000062.3 ENSP00000278407 P2P05155-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Other:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpOct 04, 2023This sequence change replaces isoleucine, which is neutral and non-polar, with lysine, which is basic and polar, at codon 232 of the SERPING1 protein (p.Ile232Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with hereditary angioedema (PMID: 22994404; Invitae). ClinVar contains an entry for this variant (Variation ID: 68255). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SERPING1 protein function. This variant disrupts the p.Ile232 amino acid residue in SERPING1. Other variant(s) that disrupt this residue have been observed in individuals with SERPING1-related conditions (PMID: 26154504), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided, no classification providedliterature onlyUniProtKB/Swiss-Prot-- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 09, 2015The p.I232K variant (also known as c.695T>A), located in coding exon 4 of the SERPING1 gene, results from a T to A substitution at nucleotide position 695. The isoleucine at codon 232 is replaced by lysine, an amino acid with dissimilar properties. This variant was detected in one patient with a diagnosis of hereditay angioedema, but absent in 53 healthy control individuals (Xu YY, Allergy 2012; 67(11):1430-6). This variant was previously reported in the SNPDatabase as rs281875172. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since clinical data on this variant is limited at this time, its clinical significance is unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.90
BayesDel_addAF
Pathogenic
0.38
D
BayesDel_noAF
Pathogenic
0.31
CADD
Uncertain
24
DANN
Benign
0.97
DEOGEN2
Pathogenic
0.81
D;.;.;.;D
Eigen
Uncertain
0.50
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Benign
0.68
D
LIST_S2
Benign
0.73
T;T;T;T;T
M_CAP
Pathogenic
0.58
D
MetaRNN
Pathogenic
0.98
D;D;D;D;D
MetaSVM
Uncertain
0.61
D
MutationAssessor
Pathogenic
2.9
M;.;.;.;.
MutationTaster
Benign
0.98
D;D;D;D;D
PrimateAI
Benign
0.48
T
PROVEAN
Pathogenic
-4.7
D;D;D;D;D
REVEL
Pathogenic
0.76
Sift
Uncertain
0.0020
D;D;D;D;D
Sift4G
Uncertain
0.024
D;D;D;D;D
Polyphen
0.99
D;.;.;.;P
Vest4
0.86
MutPred
0.88
.;.;.;.;Gain of disorder (P = 0.0065);
MVP
0.99
MPC
1.3
ClinPred
0.99
D
GERP RS
5.2
Varity_R
0.90
gMVP
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs281875172; hg19: chr11-57373492; API